Frequent Links
natural disasters open accessfluorescence journalsPsychosocial and Health Behaviors in Young AdultsBest scientific journals in arthritis researchtelecommunications-group-journalsFinancial AnalysisAsthma and SleepNanoparticlesStock-Market-Online-JournalsOpen access in phylogenitics Leading journals on Diabetes mellitus type 1Hair loss JournalsHearing Aids Peer-review JournalsEndangered Plants Online Journalssoft system methodology
Landiolol
300px | |
Systematic (IUPAC) name | |
---|---|
[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
| |
IV | |
Identifiers | |
133242-30-5 7px | |
None | |
PubChem | CID 114905 |
ChemSpider | 102855 7px |
UNII | 62NWQ924LH 7px |
Chemical data | |
Formula | C25H39N3O8 |
509.59 g/mol | |
| |
14px (what is this?) (verify) |
Landiolol (INN) is a drug which acts as a highly cardioselective, ultra short-acting beta blocker. It is used as an anti-arrhythmic agent.
References
- Yoshiya I (December 1998). "[Landiolol hydrochloride, a new sympathetic beta blocker]". Masui (in Japanese). 47 Suppl: S126–32. PMID 9921175.
- Ogata J, Okamoto T, Minami K (2003). "Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation". Can J Anaesth 50 (7): 753. PMID 12944459. doi:10.1007/BF03018726.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.